Muscarinic Acetylcholine Receptor M2 (CHRM2) Antibody

Este producto es parte de CHRM - Muscarinic acetylcholine receptor
Product Graph
292.5€ (80 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Muscarinic Acetylcholine Receptor M2 (CHRM2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx028043
tested applications
ELISA, WB

Description

The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine to these receptors and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The muscarinic cholinergic receptor 2 is involved in mediation of bradycardia and a decrease in cardiac contractility. Multiple alternatively spliced transcript variants have been described for this gene.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Muscarinic Acetylcholine Receptor M2 (CHRM2)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified through a protein A column, followed by peptide affinity purification.
Size 1
80 µl
Size 2
400 µl
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS containing 0.09% sodium azide.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P08172
Alias
CHRM2 ,M2 muscarinic acetylcholine receptor,AChR M2,Chrm-2,cholinergic receptor muscarinic 2,cholinergic receptor,cholinergic receptor, muscarinic 2, cardiac,M2 receptor,HM2
Background
Antibody anti-CHRM2
Status
RUO

Descripción

CHRM2 encodes the cholinergic receptor muscarinic 2, which is another member of the G protein-coupled receptor family and primarily couples to Gi/o proteins. Activation of CHRM2 leads to inhibition of adenylate cyclase, thereby reducing intracellular cyclic AMP (cAMP) levels and leading to decreased cellular excitability. CHRM2 is expressed in the heart, brainstem, and vagus nerve, where it plays a key role in modulating cardiovascular function and parasympathetic nervous system activity. In the heart, CHRM2 activation slows heart rate by reducing the firing rate of sinoatrial (SA) node cells, a mechanism vital for maintaining resting heart rate and promoting vagal tone. In the brain, CHRM2 is implicated in processes related to cognition, mood regulation, and stress response, making it relevant for disorders such as depression and anxiety. Genetic variations in CHRM2 have been associated with cognitive performance and psychiatric conditions, including alcohol dependence. Pharmacologically, CHRM2 antagonists are used in cardiac treatment to counteract excessive parasympathetic activity, while selective agonists may have potential therapeutic applications in improving memory function and treating mood disorders.

Related Products

EH2815

Human CHRM2 (Cholinergic Receptor, Muscarinic 2) ELISA Kit

Ver Producto
EM0925

Mouse CHRM2 (Cholinergic Receptor, Muscarinic 2) ELISA Kit

Ver Producto
ER0835

Rat CHRM2 (Cholinergic Receptor, Muscarinic 2) ELISA Kit

Ver Producto